Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
CSA Medical, Inc.
The proposed registry is a prospective, multi-center study of patients that are being currently undergoing CryoSpray Ablation™. It will also be used to catalogue retrospective data from records of patients already treated with the device. A maximum of 40 investigational sites will participate in this study.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The study population consists of patients who are being treated, or were treated, with the CryoSpray Ablation™ System for malignant or pre-malignant conditions of the esophagus, including:
* Barrett's esophagus with or without dysplasia
* Squamous dysplasia of the esophagus
* Esophageal cancer, any stage
You may not be if
Subjects with esophageal lesions whose pathology was not one of the above.
Subjects with one of the above conditions who were not treated with the CryoSpray Ablation™ System.
